FAT1 and ductal breast carcinoma in situ: For example, over-expression of the FAT1 was observed in different tumors including in DCIS breast cancer (Kwaepila et al., 2006), melanoma (Sadeqzadeh et al., 2011) and leukemia (de Bock et al., 2012).